Codexis, Inc. (CDXS) Dividend History

Codexis, Inc. is a biotechnology company specializing in enzyme engineering and development for pharmaceuticals, biofuels, and specialty chemicals. Founded in 2002, the company focuses on creating biocatalysts that enable sustainable manufacturing processes, improving efficiency and reducing environmental impact.

200 Penobscot Drive, Redwood City, CA, 94063
Phone: 650-421-8100
Website: https://www.codexis.com

Dividend History

Codexis, Inc. currently does not pay dividends

Company News

  • Codexis, a provider of enzymatic solutions for therapeutics manufacturing, will participate in the Cantor Global Healthcare Conference in New York on September 4, 2025, presenting a live webcast of their fireside chat.

    GlobeNewswire Inc.
  • Codexis (CDXS) delivered earnings and revenue surprises of 112.50% and 7.42%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: CDTX
  • Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted adjusted earnings of 6 cents per share, missing market estimates of 10 cents per share. The company’s quarterly sales came in at $335.16 million versus expectations of $315.60 million. Helix Energy Solutions shares dipped 11% to $9.13 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Janux Therapeutics, Inc. (NASDAQ: JANX) shares jumped 145% to $37.00 after the company announced updated clinical data for both of its clinical programs. Presto Automation Inc. (NASDAQ: PRST) surged 72% to $0.5657. Viking Therapeutics, Inc. (NASDAQ: VKTX) shares jumped 71.2% to $65.88 after the company announced the Phase 2 VENTURE trial successfully achieved its primary endpoint and all secondary endpoints. CXApp Inc. (NASDAQ: CXAI) gained 67% to $2.58. WeTrade Group, Inc. (NASDAQ: WETG) gained 50% to $3.36. Hims & Hers Health, Inc. (NYSE: HIMS) climbed 33.6% to $13.70 after the company reported better-than-expected fourth-quarter financial results and issued strong guidance. Biora Therapeutics, Inc. (NASDAQ: BIOR) surged 32.2% to $1.39. AdaptHealth Corp. (NASDAQ: AHCO) jumped 29.6% to $9.89 following fourth-quarter results. Codexis, Inc. (NASDAQ: CDXS) rose 29% to $4.1283. Codexis entered into exclusive licensing agreement with Roche for double-stranded DNA Ligase. Beam Therapeutics Inc. (NASDAQ: BEAM) gained 26.8% to $45.43 after the company reported fourth-quarter financial results. BigBear.ai Holdings, Inc. (NYSE: BBAI) rose 26% to $3.14. Cantor Fitzgerald analyst Yi Fu Lee maintained BigBear.ai with an Overweight and maintained $3 price target. 5E Advanced Materials, Inc. (NASDAQ: FEAM) gained 24.3% to $1.84. Earlyworks Co., Ltd (NASDAQ: ELWS) gained 24.2% to $0.7321. Earlyworks was selected as a co-creation partner for MetaMe® a meta-communication service utilizing cutting-edge technology from NTT DOCOMO, one of Japan's largest cell phone operators. The Singing Machine Company, Inc. (NASDAQ: MICS) rose 24.1% to $0.9012. SMX ...

    Benzinga
  • Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.

    Seeking Alpha
Page data last updated 09/06/2025 14:44:43 UTC